MYDA Advisors’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,500	Closed	-$108K	–	48
2018 Q3	$108K	Sell	2,500 -2,500	-50%	-$108K	0.06%	93
2018 Q2	$195K	Buy	+5,000	New	+$195K	0.09%	81